Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Buy
53
NBIX Quote, Financials, Valuation and Earnings
Last price:
$120.53
Seasonality move
:
6.31%
Day range:
$121.87 - $123.99
52-week range:
$84.23 - $157.98
Dividend yield:
0%
P/E ratio:
41.68x
P/S ratio:
5.27x
P/B ratio:
4.80x
Volume:
1.2M
Avg. volume:
1.8M
1-year change:
-13.19%
Market cap:
$12.2B
Revenue:
$2.4B
EPS (TTM):
$2.95
Neurocrine Biosciences SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
NBIX
Neurocrine Biosciences
|
05/01/2024 | 10-Q | 10-Q filing on 05/01/2024 | View Form |
|
NBIX
Neurocrine Biosciences
|
10/31/2023 | 10-Q | 10-Q filing on 10/31/2023 | View Form |
|
NBIX
Neurocrine Biosciences
|
08/01/2023 | 10-Q | 10-Q filing on 08/01/2023 | View Form |
|
NBIX
Neurocrine Biosciences
|
05/03/2023 | 10-Q | 10-Q filing on 05/03/2023 | View Form |
|
NBIX
Neurocrine Biosciences
|
11/01/2022 | 10-Q | 10-Q filing on 11/01/2022 | View Form |
|
NBIX
Neurocrine Biosciences
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
NBIX
Neurocrine Biosciences
|
05/04/2022 | 10-Q | 10-Q filing on 05/04/2022 | View Form |
|
NBIX
Neurocrine Biosciences
|
11/01/2021 | 10-Q | 10-Q filing on 11/01/2021 | View Form |
|
NBIX
Neurocrine Biosciences
|
08/03/2021 | 10-Q | 10-Q filing on 08/03/2021 | View Form |
|
NBIX
Neurocrine Biosciences
|
05/05/2021 | 10-Q | 10-Q filing on 05/05/2021 | View Form |
|
NBIX
Neurocrine Biosciences
|
11/09/2020 | 10-Q | 10-Q filing on 11/09/2020 | View Form |
|
NBIX
Neurocrine Biosciences
|
08/03/2020 | 10-Q | 10-Q filing on 08/03/2020 | View Form |
|
NBIX
Neurocrine Biosciences
|
05/06/2020 | 10-Q | 10-Q filing on 05/06/2020 | View Form |
|
NBIX
Neurocrine Biosciences
|
02/07/2020 | 10-K | 10-K filing on 02/07/2020 | View Form |
|
NBIX
Neurocrine Biosciences
|
11/04/2019 | 10-Q | 10-Q filing on 11/04/2019 | View Form |
|
NBIX
Neurocrine Biosciences
|
07/29/2019 | 10-Q | 10-Q filing on 07/29/2019 | View Form |
|
NBIX
Neurocrine Biosciences
|
04/29/2019 | 10-Q | 10-Q filing on 04/29/2019 | View Form |
|
NBIX
Neurocrine Biosciences
|
02/08/2019 | 10-K | 10-K filing on 02/08/2019 | View Form |
|
NBIX
Neurocrine Biosciences
|
11/05/2018 | 10-Q | 10-Q filing on 11/05/2018 | View Form |
|
NBIX
Neurocrine Biosciences
|
07/31/2018 | 10-Q | 10-Q filing on 07/31/2018 | View Form |
|
NBIX
Neurocrine Biosciences
|
04/30/2018 | 10-Q | 10-Q filing on 04/30/2018 | View Form |
|
NBIX
Neurocrine Biosciences
|
02/13/2018 | 10-K | 10-K filing on 02/13/2018 | View Form |
|
NBIX
Neurocrine Biosciences
|
11/01/2017 | 10-Q | 10-Q filing on 11/01/2017 | View Form |
|
NBIX
Neurocrine Biosciences
|
08/03/2017 | 10-Q | 10-Q filing on 08/03/2017 | View Form |
|
NBIX
Neurocrine Biosciences
|
05/09/2017 | 10-Q | 10-Q filing on 05/09/2017 | View Form |
|
NBIX
Neurocrine Biosciences
|
02/14/2017 | 10-K | 10-K filing on 02/14/2017 | View Form |
|
NBIX
Neurocrine Biosciences
|
11/02/2016 | 10-Q | 10-Q filing on 11/02/2016 | View Form |
|
NBIX
Neurocrine Biosciences
|
08/03/2016 | 10-Q | 10-Q filing on 08/03/2016 | View Form |
|
NBIX
Neurocrine Biosciences
|
05/05/2016 | 10-Q | 10-Q filing on 05/05/2016 | View Form |
|
NBIX
Neurocrine Biosciences
|
04/29/2016 | 10-K | 10-K filing on 04/29/2016 | View Form |
|
NBIX
Neurocrine Biosciences
|
02/11/2016 | 10-K | 10-K filing on 02/11/2016 | View Form |
|
NBIX
Neurocrine Biosciences
|
10/29/2015 | 10-Q | 10-Q filing on 10/29/2015 | View Form |
|
NBIX
Neurocrine Biosciences
|
07/29/2015 | 10-Q | 10-Q filing on 07/29/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is down 3.24% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 1.56% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is down 1.32% over the past day.
